MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Please visit our MS learning channel on YouTube, which provides hundreds of MS videos presented by MS Experts across the USA, from many of our recorded education programs. Archived here: www.youtube.com/msviewsandnews -- Additionally, please visit our Social media platforms: Facebook, Twitter, and Instagram

Important Resources for the MS community are found on the left side of this blog.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Friday, October 9, 2009

Avanir drug shows promise for MS-related pain

October 9, 2009

(Reuters) - Avanir Pharmaceuticals Inc said a late-stage trial of its neurological drug Zenvia showed encouraging proof of concept data in relieving pain associated with multiple sclerosis (MS), sending its shares up more than 16 percent.

Additional data from its STAR trial, which tested Zenvia as a treatment for pseudobulbar affect (PBA), showed that the 30/10 mg dose of the drug reduced MS-related pain in a small subset of patients with moderate-to-severe pain, Avanir said.

PBA is a condition in which patients cannot control outbursts of crying or laughing. It affects an estimated 2 million Americans with multiple sclerosis, Lou Gehrig's disease (ALS), stroke and other neurological diseases or trauma that can cause brain lesions.

Continue reading more of Avanir from this REUTERS news release

============================================

No comments: